DGX vs VSTD · P/E 22, rev $9.87B vs rev $12.8M
Quest Diagnostics Incorporated (DGX) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported DGX revenue for 2024-12-31 was $9.87B. Net income was $921.0M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the DGX and VSTD stock pages for the full models.
Not investment advice.